NeuroPace (NPCE) Other Operating Expenses (2024 - 2026)

NeuroPace's Other Operating Expenses history runs 3 years deep, the most recent figure standing at $11.6 million for Q1 2026.

• On a quarterly basis, Other Operating Expenses rose 5.27% year-over-year to $11.6 million in Q1 2026; TTM through Mar 2026 was $37.2 million, a 17.06% decrease from a year earlier, with the FY2025 full-year figure at $27.9 million, down 29.7% from the prior year.
• Other Operating Expenses grew to $11.6 million in Q1 2026 per NPCE's latest filing, from $7.0 million in the prior quarter.
• Across five years, Other Operating Expenses topped out at $22.1 million in Q4 2024 and bottomed at $5.8 million in Q3 2024.
• The 3-year median for Other Operating Expenses is $9.0 million (2025), against an average of $10.3 million.
• Biggest YoY gain for Other Operating Expenses was 98.57% in 2025; the steepest drop was 68.15% in 2025.
• Year by year, Other Operating Expenses stood at $22.1 million in 2024, then sank by 68.15% to $7.0 million in 2025, then soared by 64.84% to $11.6 million in 2026.
• Per Business Quant, the three latest NPCE Other Operating Expenses figures stand at $11.6 million (Q1 2026), $7.0 million (Q4 2025), and $6.6 million (Q3 2025).